Goldenwell Biotech, Inc. financial data

Symbol
GWLL on OTC
Location
581 Boston Mills Road, Suite 300, Hudson, OH
State of incorporation
NV
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 26, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Quick Ratio 294 % -27.2%
Debt-to-equity 556 % +1382%
Return On Equity -406 % +38.5%
Return On Assets -61.9 % +87.1%
Operating Margin -22.4K % +54.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 99M shares
Common Stock, Shares, Outstanding 99M shares 0%
Entity Public Float 12.7M USD 0%
Common Stock, Value, Issued 9.9K USD 0%
Weighted Average Number of Shares Outstanding, Basic 96.4M shares +5.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Revenue from Contract with Customer, Excluding Assessed Tax 557 USD -73.2%
Cost of Revenue 335 USD -67.9%
General and Administrative Expense 125K USD -87.7%
Operating Income (Loss) -125K USD +87.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -125K USD +87.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 25.7K USD
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD
Inventory, Net 175K USD -0.19%
Operating Lease, Right-of-Use Asset 0 USD
Assets 179K USD -4.01%
Accounts Payable, Current 0 USD
Liabilities, Current 29.1K USD -76.9%
Liabilities 199K USD +144%
Retained Earnings (Accumulated Deficit) -1.33M USD -10.3%
Stockholders' Equity Attributable to Parent -19.2K USD -118%
Liabilities and Equity 179K USD -4.01%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -137K USD +85.8%
Net Cash Provided by (Used in) Financing Activities 51.4K USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 99M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.76K USD -60.1%
Deferred Tax Assets, Valuation Allowance 280K USD +10.3%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability, Current 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year One 25.4K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 21.6K USD
Deferred Tax Assets, Operating Loss Carryforwards 280K USD +10.3%
Additional Paid in Capital 1.3M USD 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD